Prolonged Beta-lactam Infusion Better for Patients With Sepsis Prolonged Beta-lactam Infusion Better for Patients With Sepsis

Mortality in patients with sepsis is lower for those who receive prolonged intravenous infusions of antipseudomonal beta-lactams than for those who receive short-term infusions, according to a systematic review and meta-analysis of randomized trials.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Critical Care News Source Type: news
More News: Intensive Care